Lead sponsor
Stanford University
5 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
5
Trials led
1
Ongoing
162
Total enrollment
7
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
2
Phase 3
1
Not applicable
1
Trials by status
Recruiting
1
Completed
4
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Treatment With Namenda in Women at Risk for Cognitive DeclineFamily history of Alzheimer’s disease requiredN/ACompleted22
The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease PatientsMMSE 7-28Ph 3Completed17